LIU Hong-jie, GUO Zai-pei, LIU Wei-ping, WANG Lin, ZHOU Guang-ping, LI Feng-yuan, DU Xiao-ping. Immunohistochemical Stainning for Ber EP4 and EMA in the Diagnosis Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin[J].Chinese Journal of Dermatology, 2003, 36(12): 702-704.
[1] Beer TW, Shepherd P, Theaker JM. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology, 2000, 37:218-223. [2] Tellechea O, Reis JP, Domingues JC, et al. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin. Am J Dermatopathol, 1993, 15:452-455. [3] Swanson PE, Fitzpatrick MM, Ritter JH, et al. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens. J Cutan Pathol, 1998, 25:153-159. [4] Tope WD, Nowfar-Rad M, Kist DA. Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma.Dermatol Surg, 2000, 26:415-418. [5] Jones MS, Helm KF, Maloney ME. The immunohistochemical characteristics of the basosquamous cell carcinoma. Dermatol Surg,1997, 23:181-184. [6] 黄受方,瘳松林.重视WHO肿瘤组织学新分类. 中华病理学杂志, 2002, 31:101-103. [7] Zachary CB, Rest EB, Furlong SM, et al. Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma. J Dermatol Surg Oncol, 1994, 20:530-535.